Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Lennartz

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Diagnostics (Basel, Switzerland)|October 16, 2024
Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 TumorsFlorian Lutz, Soo-Young Han, Seyma Büyücek, et al.
Cancer Biomarkers : Section a of Disease Markers|January 23, 2023
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samplesKatharina Möller, Madeleine Knöll, Elena Bady, et al.
Biomedicines|December 23, 2023
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed ImmunohistochemistryTim Mandelkow, Elena Bady, Magalie C J Lurati, et al.
International Urology and Nephrology|October 1, 2023
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladderKrystian Kaczmarek, Henning Plage, Kira Furlano, et al.
Archives of Pathology & Laboratory Medicine|March 14, 2024
Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical TissueMaximilian Lennartz, Daniela Amezada, Doris Höflmayer, et al.
The Journal of Pathology. Clinical Research|December 13, 2024
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancerNatalia Gorbokon, Niklas Wößner, Viktoria Ahlburg, et al.
Cancers|July 13, 2024
Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor EntitiesAnne Menz, Julia Zerneke, Florian Viehweger, et al.
The American Journal of Surgical Pathology|January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the PancreasMaximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 17, 2024
Staining pattern of specific and cross-reacting Melan-A antibodies: A comparative study on 15,840 samples from 133 human tumor typesShiva Boroojerdi, Sören Weidemann, Anne Menz, et al.
The Journal of Pathology|April 4, 2025
A Tc1- and Th1-T-lymphocyte-rich tumor microenvironment is a hallmark of MSI colorectal cancerZhihao Huang, Tim Mandelkow, Nicolaus F Debatin, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Diagnostics (Basel, Switzerland)|October 16, 2024
Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 TumorsFlorian Lutz, Soo-Young Han, Seyma Büyücek, et al.
Cancer Biomarkers : Section a of Disease Markers|January 23, 2023
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samplesKatharina Möller, Madeleine Knöll, Elena Bady, et al.
Biomedicines|December 23, 2023
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed ImmunohistochemistryTim Mandelkow, Elena Bady, Magalie C J Lurati, et al.
International Urology and Nephrology|October 1, 2023
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladderKrystian Kaczmarek, Henning Plage, Kira Furlano, et al.
Archives of Pathology & Laboratory Medicine|March 14, 2024
Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical TissueMaximilian Lennartz, Daniela Amezada, Doris Höflmayer, et al.
The Journal of Pathology. Clinical Research|December 13, 2024
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancerNatalia Gorbokon, Niklas Wößner, Viktoria Ahlburg, et al.
Cancers|July 13, 2024
Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor EntitiesAnne Menz, Julia Zerneke, Florian Viehweger, et al.
The American Journal of Surgical Pathology|January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the PancreasMaximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 17, 2024
Staining pattern of specific and cross-reacting Melan-A antibodies: A comparative study on 15,840 samples from 133 human tumor typesShiva Boroojerdi, Sören Weidemann, Anne Menz, et al.
The Journal of Pathology|April 4, 2025
A Tc1- and Th1-T-lymphocyte-rich tumor microenvironment is a hallmark of MSI colorectal cancerZhihao Huang, Tim Mandelkow, Nicolaus F Debatin, et al.
Pageof 12